Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Dec 24:13:126.
doi: 10.1186/1471-2296-13-126.

Effectiveness of a group diabetes education programme in underserved communities in South Africa: pragmatic cluster randomized control trial

Affiliations
Randomized Controlled Trial

Effectiveness of a group diabetes education programme in underserved communities in South Africa: pragmatic cluster randomized control trial

Bob Mash et al. BMC Fam Pract. .

Abstract

Background: Diabetes is an important contributor to the burden of disease in South Africa and prevalence rates as high as 33% have been recorded in Cape Town. Previous studies show that quality of care and health outcomes are poor. The development of an effective education programme should impact on self-care, lifestyle change and adherence to medication; and lead to better control of diabetes, fewer complications and better quality of life.

Trial design: Pragmatic cluster randomized controlled trialParticipants: Type 2 diabetic patients attending 45 public sector community health centres in Cape TownInterventions: The intervention group will receive 4 sessions of group diabetes education delivered by a health promotion officer in a guiding style. The control group will receive usual care which consists of ad hoc advice during consultations and occasional educational talks in the waiting room.

Objective: To evaluate the effectiveness of the group diabetes education programmeOutcomes:

Primary outcomes: diabetes self-care activities, 5% weight loss, 1% reduction in HbA1c.

Secondary outcomes: self-efficacy, locus of control, mean blood pressure, mean weight loss, mean waist circumference, mean HbA1c, mean total cholesterol, quality of lifeRandomisation: Computer generated random numbersBlinding: Patients, health promoters and research assistants could not be blinded to the health centre's allocationNumbers randomized: Seventeen health centres (34 in total) will be randomly assigned to either control or intervention groups. A sample size of 1360 patients in 34 clusters of 40 patients will give a power of 80% to detect the primary outcomes with 5% precision. Altogether 720 patients were recruited in the intervention arm and 850 in the control arm giving a total of 1570.

Discussion: The study will inform policy makers and managers of the district health system, particularly in low to middle income countries, if this programme can be implemented more widely.

Trial register: Pan African Clinical Trial Registry PACTR201205000380384.

PubMed Disclaimer

References

    1. Bradshaw D, Norman R, Schneider M. A clarion call for action based on refined DALY estimates for South Africa. SAMJ. 2007;97(6):438–440. - PubMed
    1. International Diabetes Foundation. Diabetes Atlas. 3. Brussels: International Diabetes Foundation; 2008. Available from Atlas: http://www.eatlas.idf.org.
    1. Mollentze W, Levitt N. In: Chronic Diseases of Lifestyle in South Africa: 1995–2005. Steyn K, Fourie J, Temple N, editor. Cape Town: South African Medical Research Council; 2006. Diabetes Mellitus and Impaired Glucose Tolerance in South Africa; pp. 109–121.
    1. Matsha TE, Hassan MS, Kidd M, Erasmus RT. The 30-year cardiovascular risk profile of South Africans with diagnosed diabetes, undiagnosed diabetes, pre-diabetes or normoglycaemia: The Bellville, South Africa pilot study. Cardiovasc J Afr. 2012;23(1):5–11. doi: 10.5830/CVJA-2010-087. - DOI - PMC - PubMed
    1. Levitt N, Bradshaw D, Zwarenstein M, Bawa A, Maphumolo S. Audit of public sector primary diabetes care in Cape Town. Diabet Med. 1997;14:1073–1077. doi: 10.1002/(SICI)1096-9136(199712)14:12<1073::AID-DIA498>3.0.CO;2-9. - DOI - PubMed

Publication types

Substances